[The clinical evaluation of vasopressin in the treatment of aphasias].
At residual stage of stroke 64 patients with different forms of aphasia were administered intranasally subendocrine doses of 1-desamino-8-D-argininvasopressin (adiuretin-SD). It was established that peptide activates expressive and impressive speech of patients. Improvement of speech occurred in 79% of cases.
Belokoskova
S G
SG
Dorofeeva
S A
SA
Klement'ev
B I
BI
Balunov
O A
OA
D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D001037:Aphasia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014667:Vasopressins